Clinical Trial: Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer (CA9CRM)

Sponsor and Collaborators
Centre Hospitalier Universitaire de Saint Etienne

Contact
Jacques Tostain, MD
+33 (0) 4 77 82 31

Guorong Li, MD PhD
+33 (0) 4 77 12 05 12

Principal Investigator
Nicolas Mottet, MD
CHU de Saint-Etienne

ClinicalTrials.gov Identifier
NCT00942058